Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Bioxytran (BIXT) Other Non-Current Assets (2012)

Updated

Bioxytran (BIXT) reported Other Non-Current Assets of -$15,633 for Q4 2012.

Analysis

Bioxytran (BIXT) Other Non-Current Assets (2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 14.27 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.73 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 4.75 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.25 Bn
10 Bioxytran 2.29 Mn 1.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 -15,633.00
API Access

Bioxytran Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BIXT&period=max&api_key=YOUR_API_KEY